Glucagon was administered exogenously via a subcutaneous route to totally depancreatized adult mongrel dogs and studies were made with major emphasis on glucagon effect on the plasma glucose levels.
Introduction
A great many findings have been reported on the mechanism of action of insulin used after total pancreatectomy in connection with the treatment of diabetes occurring frequently after the operation1). On the other hand, a number of aspects still remain in the realm of the unknown as to the action of glucagon on the pathophysiology in patients who have undergone total pancreatectomy. The major physiological action of pancreatic glucagon is to increase plasma glucose levels as a result of hepatic glycolysis 2) and glyconeogenesis; besides, it is known that it has many other actions such as lypolysis 3) and acceleration of insulin secretion4,S). But how exgenously administered glucagon acts on individuals who are deficient in pancreatic glucagon as a result of total pancreatectomy is almost unknown. The usefulness of glucagon given clinically for the treatment of hypoglycemic shock after total pancreatectomy has not fully been studied. For these reasons, in this paper the authors gave glucagon by various methods to totally depancreatized dogs and studied mainly its hyperglycemic effect and at the same time considered from the standpoint of glucose metabolism the mechanism of hypergylcemic action of glucagon exogeously administered to totally depancreatized dogs.
Materials and Methods

A. Preparation of totally depancreatized
dogs: Adult mongrel dogs weighing 8-15kg were fasted for 24 hours and underwent total pancreatectomy under Nembutal anesthesia given intraveously in a dose of 25 mg/kg. In the surgical intervention, only the pancreas was removed while the pancreaticoduodenal artery and vein were preserved. After the surgery, the dogs were fed on commercially obtained dog food. As soon as oral feeding became feasible, usually on and after the second or third day after the surgery, lente insulin produced by Novo was given to the dogs subcutaneously once a day in a dose of 0.5-1.0 U/kg. The dogs used in the current experiment were selected from totally depancreatized dogs which had survived for more than two weeks after the operation and had been in good general condition without any post-operative complication. All blood specimens were collected under various experimental conditions from the totally depancreatized dogs under Nembutal anesthesia given intraveously in a dose of 25 mg/kg after the dogs were given Novo lente insulin subcutaneously in a dose of 0.5U/kg and then fasted for 24 hours. Blood specimens were obtained from a jugular vein using a 19G Elaster needle and immediately transferred to cooled test tubes. A group of healthy, nontreated adult mongrel dogs weighing 8-15kg each served as the control group. The dogs were fasted for 24 hours and treatd by the same procedure as that used for the totally depancreatized dogs. Then blood specimens were collected. B. Methods of administration of glucagon and other drugs and collection of blood specimens: 1. Glucagon was given subcutaneously in a dose of 40/.tg/kg to 6 normal dogs and 11 totally depancreatized dogs and blood specimens were collected from a peripheral vein before the injection and 5, 10, 20, 30, 40, 50, 60, 90 and 120 minutes after the injection to determine fluctuations in plasma glucose levels.
2. Four totally depancreatized dogs were given regular insulin in a dose of 0.25 U/kg by one shot into a peripheral vein, and 90 minutes later glucagon was administered subcutaneously in a dose of 40//g/kg. (It has been confirmed by Konishi et al. 6 ) that hypoglycemia is caused 90 minutes after insulin treatment.) Blood specimens were collected from a peripheral vein before the injection of regular insulin and 10, 30 and 60 minutes after the injection, and immediately before glucagon injection in order to determine fluctuations in plasma glucose levels. At the same time, an assimilation index was calculated on the basis of the fluctuations in plasma glucose levels following insulin injection in accordance with Norgaad & Thaysen's method 7) (Fig. 1) . In addition, regular insulin was injected in the same manner to 5 normal dogs in a dose of 0.25U/kg into a peripheral vein and an assimilation index was calculated on the basis of the fluctuations in plasma glucose levels following the injection. The index thus obtained served as the control value. 3. In 3 totally depancreatized dogs, physiological salt solution containing both insulin and glucose was infused continuously into a peripheral vein at the rate of 0.83mU/kg/min for insulin and 0.4mg/ kg/min for glucose while glucagon was given subcutaneously in a dose of 40/2g/kg 120 minutes after initiation of the infusion. Blood specimens were collected from a peripheral vein 120, 90, 60, 30 minutes and immediately before glucagon injection, and 10, 20, 30, 60, 90 and 120 minutes after glucagon injection to determine insulin levels in the blood.
4. Glucagon was given subcutaneously in a dose of 40/2g/kg to 5 normal dogs and 5 totally depancreatized dogs and blood specimens were collected from a peripheral vein before the injection and 5, 10, 20, 30, 40, 50, 60, 90 and 120 minutes after the injection to measure glucagon levels in the blood. C. Methods of collection of blood and measurement of plasma glucose, plasma insulin and plasma glucagon levels: Blood specimens were taken from a jugular vein with syringes rinsed with an anticoagulant, and 1 mg of sodium fluoride per 1 ml of blood was added for measuring plasma glucose, and 1.2rag of EDTA with 1,000 units of Trasylol per l ml of blood was added for plasma glucagon determination.
The plasma was separated immediately and stored at -20~ for 30 days or less. Plasma glucose level was measured by the orthotoluidine methodS). Plasma insulin was assayed radioimmunologically by the dextrancoated charcoal separation method 9) using CEA-IRE-SORIN kits (INSIK-3), and plasma glucagon by the technique of Unger et al.10), using the dextran-coated charcoal separation method~a), in which 30-K antibody that had been purchased from the University of Texas South Western Medical School in Dallas was used.
Results
A. Early morning fasting plasma glucose levels: As shown in Fig. 2 , the average early morning fasting plasma glucose level in 13 normal dogs was 88.6+12.9mg/dl (M-+SEM). The average early morning fasting plasma glucose level in each group of totally depancreatized dogs was as follows. The level was 304.8+69.7mg/dl in 25 dogs in which the measurement was made less than 3 weeks after the surgery, 259.4+45.3mg/dl in 16 dogs in which the determination was made 3-5 weeks after the operation, and 360.2+32.4mg/dl in 21 dogs in which the measurement was made more than 5 weeks after the operation (P<0.05). B. Changes in plasma glucose levels, plasma insulin levels and plasma glucagon levels before and after glucagon injection: 1. Changes in plasma glucose levels before and after glucagon injection:
As shown in Fig. 3 , the plasma glucose levels in 6 normal dogs given glucagon subcutaneously in a dose of 40pg/kg reached the maximum 30-40 minutes after the injection, and after that the highest levels were maintained almost constantly. It was 120 minutes after the injection when the levels showed a tendency to decrease. The plasma glucose levels in 11 totally depancreatized dogs which survived for 2 weeks or more after the surgery and which were given glucagon subcutaneously in a dose of 40pg/kg are shown in Fig. 4 . The pattern of an increase in the plasma glucose level varied depending on the individual dogs; in some dogs the levels showed a rapid increase following the injection, while in others the levels remained almost the same as the relatively high pretreatment levels with little fluctuation after the injection. Then the dogs were divided into 3 groups on the basis of the plasma glucose level before the injection of glucagon; the first group consisting of dogs in which the pretreatment plasma glucose levels were lower than 100mg/dl, the second group consisting of dogs with the pretreatment level of 100-400mg/dl and the third group consisting of dogs in which the pretreatment levels were higher than 400mg/dl. Then fluctuations in the plasma glucose levels following glucagon injection in these groups were studied.
In the group of dogs in which the pretreatment plasma glucose levels were lower than 100mg/dl, the levels showed a rapid increase during 20 minutes after glucagon injection and then rose gradually during the subsequent period of 100 minutes.
In the group of dogs with the pretreatment plasma glucose levels of 100-400mg/dl, as a whole, gradual increases in the levels were observed during 120 minutes after the injection of glucagon. In some of the dogs in which the pretreatment levels were relatively low, increases in the levels after the injection were marked, while in others with high pretreatment levels increases in the levels after the injection were gradual and in some of the latter dogs the levels tended to decrease 120 minutes after the injection.
In the group of dogs in which the pretreatment plasma glucose levels were higher than 400 mg/dl, as a whole no increase in the levels was noted.
The rate of increase in the plasma glucose levels 90 minutes after glucagon injection as compared with the pretreatment levels was calculated in each of the 3 groups. As a result, it was found that the rate was 5. 13 • times (M• as high as the pretreatment level (P<0.05) in the group in which the pretreatment level had been lower than 100mg/dl, 1.62• times (M• as high as the pretreatment level (P<0.05) in the group with the pretreatment level of 100-400mg/dl, and 0.90+0.07 times (M• as high as the pretreatment level (with no significant difference between the pre-and post-treatment levels) in the group in which the pretreatment level had been higher than 400 mg/dl (Fig. 5) .
In the totally depancreatized dogs, the lower the pretreatment glucose levels were, the more marked . was the hyperglycemic effect of glucagon. i 2. Fluctuations in plasma glucose levels before and after the injection of insulin and glucagon:
In 5 normal dogs, regular insulin was injected in a dose of 0.25 U/kg by one shot into a peripheral vein and the plasma glucose levels after the injection was determined. The levels were 83. In 4 totally depancreatized dogs, regular insulin was injected into a peripheral vein in a dose of 0.25U/kg, and 90 minutes later glucagon was given subcutaneously in a dose of 40 pg/kg to determine fluctuations with time in the plasma glucose levels (Fig. 6) . Fig. 6 : In Dog A, the plasma glucose level before insulin injection was 120.2 mg/dl, which was reduced to 57.4mg/dl 90 minutes after the injection. In this dog, a marked rise in the blood glucose levels Rate (times)= blood glucose level before glucagon injection plasma glucose level was noted following glucagon injection, and the rate of increase in the plasma glucose level 120 minutes after the injection of glucagon was 5.02 times as compared with the level before glucagon injection. In Dog B, the plasma glucose level before insulin injection was 319.8 mg/dl, which was reduced to 140.3mg/dl 90 minutes after the injection. In this dog, the rate of increase in the plasma glucose level 120 minutes after glucagon injection was 2.73 times the level before the injection of glucagon. In Dog C, the plasma glucose level before insulin injection was 252.2/dl, which was reduced to 172.3 mg/dl 90 minutes after the injection. In this dog, the rate of increase in the plasma glucose level 120 minutes after the injection of glucagon was 2.35 times as high as the level before the injection of glucagon. In Dog D the plasma glucose level before insulin injection was 420.3mg/dl, which was lowered to 305,0mg/dl 90 minutes after the injection. In this dog, the rate of increase in the plasma glucose level 120 minutes after glucagon injection was 1.18 times as compared with the level before the injection of glucagon.
As shown in the above, the totally depancreatized dogs having marked hypoglycemia following insulin injection tended to show a marked increase in the plasma glucose level after glucagon injection.
Then, relation between the glucose assimilation index following insulin injection and the rate of increase in the plasma glucose level 120 minutes after glucagon injection was studied in the totally depancreatized dogs.
In Dog A, the plasma assimilation index of 1.02 and the rate of increase in the plasma glucose level was 5.02 times. In Dogs B, C and D, the glucose assimilation inde and the rate of increase in the plasma glucose level were 0.62 and 2.73 times, 0.35 and 2.35 times, and 0.30 and 1.18 times, respectively. As mentioned in the above, there was positive correlation between the glucose assimilation index after insulin injection and the rate of increase in the plasma glucose level following glucagon injection.
3. Fluctuations in the plasma insulin levels before and after glucagon injection during continuous administration of a mixture of insulin and glucose:
A mixture of insulin and glucose was given to totally depancreatized dogs by continuous drip infusion at the rate of 0.83mU/kg/min for insulin and 0.4mg/kg/min for glucose, and glucagon was administered sbucutaneously to them in a dose of 40/tg/kg two hours after administration of the mixture was initiated in order to determine fluctuations in the plasma insulin levels (Fig. 7) . As a result, it was found that the plasma insulin levels in these dogs ranged from 5.0pU/ml to 19.0/~U/ml before glucagon injection, and reached the peak levels of 35, 26 and 29pU/ml during the period from 10 to 60 minutes after glucagon injection. Thus it was confirmed that insulin which had been given exogenously after total pancreatectomy and incorporated into the tissue was released into the blood again as a result of glucagon injection.
4. Rate of disappearance of subcutaneously administered glucagon from the blood:
Glucagon was given subcutaneously in a dose of 40pg/kg to normal dogs and totally depancreatized dogs and the glucagon levels in a peripheral vein was determined with the lapse of time (Fig. 8) . In both the normal and totally depancreatized dogs, the plasma glucagon levels reached the maximum 20-30 minutes after glucagon injection and they were rapidly lowered. The rate of disappearance of glucagon from the blood varied depending on the individual dogs, but there was no statistically significant difference in the rate betweet the normal dogs and the totally depancreatized dogs.
Discussion
Many studies have been made on pathophysiology following total pancreatectomy. A relatively large number of studies have been carried out on insulin and this agent is now being used widely, but many aspects still remaining in the realm of the unknown as to glucagon. Since pancreatic glucagon as well as insulin is not present after total pancreatectomy, the factors which control the upper and lower limits of plasma glucose are lost and it is characteristic that post-operative plasma glucose levels are labile and fluctuant with great diural and day-to-day variations. In the post-operative management of total depancreatized patients showing the features of brittle diabetes, the most important thing to be considered is hypoglycemic shock which occurs after insulin injection. In fact, the study made by Konishi et al. 6) showed that in totally depancreatized dogs given insulin, the half-life of plasma insulin was more prolonged as compared with that in normal dogs, the plasma glucose levels were gradually lowered and recovery from the hypoglycemic state was markedly delayed or did not occur at all. Usually intraveous or oral administration of glucose is used for recovery from hypoglycemic shock, but glucagon is featured by its simple use via a subcutaneous route. However, it is almost unknown how glucagon given exogenously to totally depancreatized pantients lacking endogeous pancreatic glucagon exerts its hyperglycemic action. In addition, how lack of pancreatic glucagon takes part in the mechanism of disturbance of carbohydrate metabolism also remains in the realm of the unknown in many aspects. Therefore, in the current study, exogeous glucagon was given subcutaneously to totally depancreatized dogs prepared experimentally by various methods and analysis was made with major emphasis being placed on subsequent fluctuations in the plasma glucose levels. When insulin was given in an equal dose once a day to individual dogs after total pancreatectomy, the post-operative palsma glucose levels varied greatly depending on the individual dogs and their fasting plasma glucose levels ranged from 100 mg/dl or less to 400 mg/dl or more. In case glucagon was given to some of the dogs in which the fasting plasma glucose levels had been almost normal or below the normal value, a rapid rise in the level was noted 30-40 minutes after glucagon injection. The rate of increase in the level was several times that in the normal dogs given glucagon in the same dose. In the totally depancreatiaed dogs in which the plasma glucose levels had been well controlled or which had been slightly hypoglycemic, glucagon had a very marked hyperglycemic action, while in the totally depancreatized dogs in which high plasma glucose levels had been maintained, that is, in those in which the plasma glucose levels had been poorly controlled, glucagon given in the same dose did not have a marked hyperglycemic action. Then, regular insulin was administered intraveously by one shot to the totally depancreatized dogs which had been controlled with lente insulin given every day, and glucagon was given to them subcutaneously 90 minutes after the injection of regular insulin in order to determine changes with time in the plasma glucose levels. (It has been shown that the plasma glucose levels are reduced to minimum 90 minutes after the injection. See the report published by Konishi et al.S)).
The results showed that the more marked the hypoglycemic effect of insulin was in the totally depancreatized dogs, the more pronounced the hyperglycemic effect of glucagon, while in the Vol. 13, No. 6 totally depancreatized dogs in which hypoglycemia had not been caused with insulin, the hyperglycemic effect of glucagon was mild. For example, in the dog in which the plasma glucose level had been reduced to as low as 57.4mg/dl following the intraveous administration of insulin, a rise in the level started 5-10 minutes after glucagon was given subcutaneously in a dose of 40/.tg/kg and then the level continuously rose, reaching 287.9mg/dl 120 minutes after glucagon injection. Such a marked hyperglycemic effect of glucagon was never noted in any normal dog.
This tinging was studied further on the basis of a difference in the glucose assimilation index. As a result, it was found that the rate of increase in the plasma glucose level following glucagon injection was higher in the totally depancreatized dogs in which tb.e glucose assimilation index after insulin injection had been almost normal, while it was lower in the totally depancreatized dogs in which the glucose assimilation index after insulin injection had been lower than normal.
This correlation between the glucose assimilation index following insulin injection and the rate of increase in the plasma glucose level after glucagon injection suggests, as described below, the fact that there is a close relation between plasma glucose levels and dysfunction of the target organ, that is, the liver.
It is considered that the hyperglycemic effect of glucagon particularly marked after total pancreatectomy is probably produced mainly by lack of endogenous insulin which is able to be released by glucagon, but at the same time it is suggested that the amount of glycogen stored in the liver and the mechanisms of glycolysis, glyconeogenesis and release of glucose into the blood from the tiver are well preserved in case plasma glucose levels are satisfactorily controlled with insulin following total pancreatectomy. In fact, in the current experiment the amount of glycogen in the liver was studied histochemically and as a result it was observed that hepatic glycogen was abundantly distributed throughout the hepatic lobules in the dogs in which the plasma glucose levels had been relatively satisfactorily controlled with insulin after total pancreatectomy and it was also noted in these dogs that a marked rise in the plasma glucose level occurred after the subcutaneous injection of glucagon and at the same time hepatic glycogen was reduced. On the other hand, in the hyperglycemic dogs in which the plasma glucose levels had been controlled only poorly with insulin, the amount of glycogen stored in the liver was smaller than that in the well controlled dogs, and unlike the well controlled dogs neither reduction in hepatic glycogen nor rise in the plasma glucose level was noted even after glucagon injection. Fig. 9.A and 9 .B show the PAS-stained specimens of hepatic tissue obtained befor and after the injection of glucagon from the dog 2 weeks after total pancreatectomy. Fig. g .A indicates the specimen of hepatic tissue obtained from the dog in which the plasma glucose level had been controlled satisfactorily with insulin and Fig. 9 .B shows the specimen of hepatic tissue obtained from the hyperglycemic dog in which the plasma glucose level had been controlled only poorly. In the former dog, it is noted that glycogen stored abundantly in the hepatic lobules before glucagon injection was markedly reduced after the injection. In the latter dog, however, glycogen had been reduced even before glucagon injection and there was almost no change in the amount of glycogen after the injection. As seen in these dogs, a large amount of hepatic glycogen was indispensable for a hyperglycemic reaction to glucagon, and it was shown that satisfactory control of the plasma glucose leve with insulin was essential to store a b u n d a n t glycogen in the liver. From the same viewpoint, Kibler et al. ~,~s) reported taht hepatic glycogen was in deficiency in patients with hepatic diseases such as hepatic cirrhosis who h a d shown only a weak hyperglcemic of glucagon given intravenously. Linke 14) described that the hyperglycemic reaction of glucagon was mild in noncompensatory hepatic cirrhosis and acute hepatitis and one of the reasons for this was lack of hepatic glycogen. Marble et al. xS) also reported that hepatic glycogen was often reduced in diabetics in whom the plasma glucose had poorly been controlled with insulin.
On the other hand, Hildes et al. x6) reported that the amount of glycogen in diabetic liver was never correlated with the type of diabetes and the fasting plasma glucose level, and Linke pointed out that a b n o r m a l i t y of certain enzymatic systems in the liver might coexist with lack of hyperglycemic reaction to glucagon in hepatic disease. Steiner et al.~7) demonstrated a reduction in glycogen synthetase in diabetics. In view of these findings, the authors made a histological follow-up study on changes in the activity of various hepatic enzymes which participate in sugar metabolism on the third and 7th days after total pancreatectomy in the totally depancreatized dogs which h a d not been given insulin post-operatively.
As a result, it was confirmed that in normal dogs, the activity of such enzymes as hexokinase is) showing a potent activity at the central zone of hepatic lobules and G-6-PD xg) having a more potent activity at the peripheral zone of hepatic lobules was markedly reduced as time went on after total pancreatectomy. On the other hand, it was also observed that the activity of gluconeogenic enzymes such as G-6-Pase ~0) and FDPase 21) showing a potent activity at the peripheral zone of hepatic lobules was enhanced after total p a n c r e a t e c t o m y ( T a b l e 1).
On the basis of the above-mentioned findings, it is considered that when control of the plasma glucose level with insulin is poor after total pancreatectomy, the activity of hepatic enzymes taking part in sugar metabolism becomes a b n o r m a l and at the same time a deficiency in hepatic gylcogen occurs, thus leading to a reduction in the hyperglycemic reaction to exogenous glucagon.
In the above, it was shown that a hyperglycemic reaction more marked than in the normal dogs occurred after glucagon injection in the totally depancreatized dogs which had been well controlled with insulin and in those which had developed hypogylcemia as a result of insulin loading, and the most probable mechanism of this hyperglycemic reaction is, as mentioned above, a deficiency in endogenous insulin. It is well known that in normal cases secretion of insulin is promoted following glucagon injection, and the plasma glucose levels increased after glucagon loading in normal cases return to the preloading values after lapse of a certain period of time as a result of acceleration of insulin secretion. However, it was observed that in the totally depancreatized dogs the plasma insulin levels rose transiently when glucagon was administered exogenously while a mixture of glucose and insulin was infused continuously. Probably this was caused by the fact that insulin which had been incorporatd into the tissue was released again into the blood by glucagon. However, these results seem to be full of suggestions as to clarification of the mechanism of accelerated insulin secretion.
In the meanwhile, since abnormality of the function of various organs throughout the body is caused after total pancreatectomy, though the degree of the abnormality varies depending on individuals, the possibility can not be excluded that abnormality of metabolism of glucagon given exogenously, that is, acceleration or inhibition of incorporation of glucagon into the tissue and of destruction of glucagon may develop, resulting in occurrence of a plasma glucose reaction, which is something different from normal. In order to clarify this point, a follow-up study was carried out on changes with time in plasma glucose levels in totally depancreatized dogs given glucagon, but there was no significant 
